Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Agios Pharmaceuticals, Inc. (NASDAQ: AGIO).

Full DD Report for AGIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: AGIO)

Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Ultragenyx Pharmaceutical
NEW YORK, NY / ACCESSWIRE / September 6, 2018 / Major U.S. equities were mixed on Wednesday with tech stocks posting worst daily drop since July dragging Nasdaq lower. The Dow Jones Industrial Average was up 0.09 percent to close at 25,974.99, while the S&P 500 Index decreased 0.28 percen...
Source: ACCESSWIRE IA
Date: September, 06 2018 08:00
Agios Pharma and Celgene terminate partnership developing AG-881
Agios Pharmaceuticals (NASDAQ: AGIO ) and Celgene (NASDAQ: CELG ) have mutually agreed to terminate their collaboration and license agreement inked on April 27, 2015, to develop and commercialize products containing pan-IDH inhibitor AG-881. More news on: Agios Pharmaceuticals, Inc., Cel...
Source: SeekingAlpha
Date: September, 05 2018 07:39
Agios Pharma names former Celgene exec Fouse as next CEO
Agios Pharmaceuticals (NASDAQ: AGIO ) names former Celgene president and COO Jacqualyn Fouse as its next CEO , succeeding David Schenkein, who will become executive chairman effective next February. More news on: Agios Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: September, 04 2018 18:46
Agios Announces Chief Executive Officer Succession Plan
- David Schenkein, M.D., Agios Long-Time Chief Executive Officer, to Become Executive Chairman, Effective February 1, 2019 - - Jacqualyn Fouse, Ph.D., to Succeed Dr. Schenkein as Chief Executive Officer - CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, I...
Source: GlobeNewswire
Date: September, 04 2018 17:57
Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018
CAMBRIDGE, Mass, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Citi 13 th Annual Biotech Conference in Bost...
Source: GlobeNewswire
Date: August, 28 2018 07:00
Key events next week - healthcare
Noteworthy events during the week of August 19 - 25 for healthcare investors. More news on: Neurocrine Biosciences, Inc., Agios Pharmaceuticals, Inc., Mallinckrodt PLC, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 17 2018 07:40
Agios Pharmaceuticals, Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Agios Pharmaceuticals, Inc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 02 2018 14:12
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q2 2018 Results - Earnings Call Transcript
Agios Pharmaceuticals, Inc. (AGIO) Q2 2018 Results Conference Call August 2, 2018 8:00 AM ET Executives Renee Leck – Senior Manager-Investor Relations David Schenkein – Chief Executive Officer Chris Bowden – Chief Medical Officer Steve Hoerter – Chie...
Source: SeekingAlpha
Date: August, 02 2018 13:47
Agios Pharmaceuticals beats by $0.36, beats on revenue
Agios Pharmaceuticals (NASDAQ: AGIO ): Q2 EPS of -$1.19 beats by $0.36 . More news on: Agios Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 02 2018 07:03
Agios Reports Second Quarter 2018 Financial Results
– TIBSOVO ® Launch Underway Post FDA Approval for IDH1m R/R AML; Second Medicine Approved from Agios’ Discovery Platform in 12 Months – – Entered License Agreement with CStone Pharmaceuticals to Develop and Commercialize Ivosidenib in Greater Ch...
Source: GlobeNewswire
Date: August, 02 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0879.3976.6479.4176.03332,411
2018-05-1786.4786.0186.7984.95157,587
2017-06-2051.8952.7554.2551.42764,640
2017-06-1952.0151.7652.6551.26427,255
2017-06-1650.4651.7751.8550.0611569,726

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1062,091223,37927.7963Cover
2018-12-0797,183199,78348.6443Short
2018-12-0679,359146,20254.2804Short
2018-12-0499,988446,35922.4008Cover
2018-12-03248,420923,83826.8900Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AGIO.


About Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)

Logo for Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: AGIO)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 04 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 04 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 18 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 18 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 13 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: February, 14 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: February, 14 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: February, 14 2018

       

       


      Daily Technical Chart for (NASDAQ: AGIO)

      Daily Technical Chart for (NASDAQ: AGIO)


      Stay tuned for daily updates and more on (NASDAQ: AGIO)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: AGIO)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AGIO and does not buy, sell, or trade any shares of AGIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/